DNA

Noom Introduces Industry-First $149 Compounded GLP-1 with a Taper-Off Guarantee, Offering a Sustainable Approach to Long-Term Weight Loss

Starting price of $149 offers improved accessibility compared to market prices of brand-name medications which can be 8x higher.Noom stands…

1 year ago

CVRx announces new publication reinforcing the long-term quality of life benefits of Barostim

New data published in JACC: Heart Failure demonstrate durable benefits in MLWHF and EQ-5D quality of life measures in heart…

1 year ago

Fulcrum Therapeutics Announces Topline Results from Phase 3 REACH Clinical Trial of Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD)

― Losmapimod failed to show an improvement in relative surface area (RSA), a measure of reachable workspace (RWS), versus placebo…

1 year ago

Peer-Reviewed Study Validates Reliability and Reproducibility of Esopredict, Previse’s Prognostic Assay for Patients with Barrett’s Esophagus

BALTIMORE, Sept. 11, 2024 /PRNewswire/ -- Previse, a gastrointestinal health company, announced the publication of a study in Diagnostics highlighting the…

1 year ago

Global Health Exhibition Announces Opportunity for Healthcare Startups to secure over 100,000 SAR in Vision NextGen Competition Designed to Fast-Track Health Innovations

Healthcare innovators developing novel medical advancements via their own business invited to compete for a prize fund exceeding 100,000 Saudi Riyal…

1 year ago

Applied DNA Launches Mpox Clade I and Clade II Testing Service

STONY BROOK, NY / ACCESSWIRE / September 11, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in…

1 year ago

Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform – Provides Access to 45 Healthcare Systems and 250 Clinics

MELBOURNE, Australia, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader…

1 year ago

Volta Labs Announces First Customer Shipments and Expanding Preloaded App Menu

BOSTON, Sept. 10, 2024 /PRNewswire/ -- Volta Labs, a genomics applications company, announced today that the Callisto™ Sample Prep System has…

1 year ago

Korro to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing…

1 year ago

Altimmune Presents Results of a Phase 2 MRI-Based Body Composition Sub-Study at 60th Annual Meeting of the European Association for the Study of Diabetes

Lean Loss Ratio of only 21.9%, representing class-leading preservation of lean mass Maintenance of lean mass preservation in individuals over…

1 year ago